Table 1.
Baseline Characteristics of Subjects Without VTE With/Without Atrial Fibrillation During Follow‐up and of Subjects With VTE During Follow‐up With/Without Subsequent Atrial Fibrillation During Follow‐up
| No VTE During Follow‐up | VTE During Follow‐up | |||
|---|---|---|---|---|
| No Atrial Fibrillation | Atrial Fibrillation | No Atrial Fibrillation | Subsequent Atrial Fibrillation | |
| Subjects, n | 27 815 | 1612 | 490 | 50 |
| Sex (male), % | 47.0 (13 065) | 55.7 (898) | 46.3 (227) | 42.0 (21) |
| Age, y | 45.2±14.0 | 64.0±11.7 | 56.8±14.2 | 68.3±9.4 |
| BMI, kg/m2 | 25.2±3.9 | 26.9±4.3 | 26.7±4.4 | 29.2±4.0 |
| Total cholesterol, mmol/L | 5.93±1.29 | 6.68±1.24 | 6.56±1.35 | 6.94±1.18 |
| HDL cholesterol, mmol/L | 1.49±0.41 | 1.51±0.44 | 1.51±0.43 | 1.51±0.38 |
| Systolic blood pressure, mm Hg | 132±20 | 152±24 | 141±22 | 159±21 |
| Diastolic blood pressure, mm Hg | 77±12 | 86±14 | 81±13 | 88±13 |
| Smoking, % | 36.5 (10 121) | 27.3 (439) | 32.7 (160) | 22.0 (11) |
| Self‐reported CVD*, % | 4.9 (1362) | 23.4 (376) | 11.0 (54) | 22.0 (11) |
| Self‐reported diabetes, % | 1.6 (448) | 5.3 (85) | 2.5 (12) | 6.0 (3) |
Values are given as percentages with absolute numbers in brackets or as means±standard deviations. BMI indicates body mass index; CVD, cardiovascular disease; HDL, high‐density lipoprotein; VTE, venous thromboembolism.
*
Self‐reported history of cardiovascular disease (angina pectoris, myocardial infarction, or stroke).